COSCIENS Biopharma (CSCI) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CSCI COSCIENS Biopharma

Watchlist

2.675
-0.120-4.28%

Close Dec 27 16:00 ET

2.675
0.0000.00%

Post 16:00 ET

8.36MMarket Cap-0.60P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cosciens Biopharma Down 3.3% As Repositions as Life Sciences Business
MT NewswiresDec 23 11:16 ET
COSCIENS Biopharma Halts Investment in Macimorelin; CMO to Depart
Seeking AlphaDec 23 08:49 ET
COSCIENS Biopharma Shifts Focus to Natural-Based Products for Health & Wellness
BenzingaDec 23 07:46 ET
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
GlobeNewswireDec 23 07:45 ET
COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 Loss per Share (Vs US$3.41 Loss in 3Q 2023)
Yahoo FinanceNov 15 05:10 ET
COSCIENS Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)
SECNov 12 09:30 ET · Announcements

Comments

Jaguar8

Dec 23 06:52

NEWS

$COSCIENS Biopharma (CSCI.US)$
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
Monday, 23rd December at 7:45 am
Company leveraging core competencies to develop and commercialize
natural-based products to improve health and wellness
Streamlined efficiencies and cost cutting measures taken to refine operations and development pathway forward
New corporate presentation outlining key development areas to be available in January 2025
TORONTO, ONTARIO, Dec...

Jaguar8

Sep 23 06:54

NEWS

$COSCIENS Biopharma (CSCI.US)$
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ:CSCI) (TSX:CSCI) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today provided an update on the progress of its merger...

The Thinker

Aug 27 19:48

Dow Hits Record High as Tech Stocks Await Nvidia Earnings

Click Here: TYNKR LAB™
U.S. equities ended the trading day with mixed results, reflecting cautious investor sentiment amid ongoing tech stock rotation and the anticipation of potential interest rate cuts by the Federal Reserve. $Dow Jones Industrial Average (.DJI.US)$ closed at a new record high of 41,250.50, up 0.02% (or 9 points). Meanwhile, both the $S&P 500 Index (.SPX.US)$ and $Nasdaq Composite Index (.IXIC.US)$ gained 0.2%.
Key Stock M...

NVIDIA's stock fluctuated after earnings: Up or down next?

Trytosaveabit

Aug 27 11:23

Hehehe! Right again! Wow that sure sounds Conceited! Hehehe

$COSCIENS Biopharma (CSCI.US)$ But i did say the crash that was coming after halt come off would be a opportunity! Well halt came off, it dropped below 2.20! Its now over 4.00! Looks like it was a pretty awesome opportunity! 💵🥂Hehehe

Trytosaveabit

Aug 27 06:55

This will more than likely crash down!

$COSCIENS Biopharma (CSCI.US)$ But a bit of why i think it still may present a opportunity! NFA just sharing some information

Heat List

Overall

No Data